New drink draws criticism

February 12, 2007

Connecticut's attorney general has opened an investigation into the calorie-burning claims of a caffeinated drink from the Coca-Cola and Nestle companies.

Called Enviga, the 5-calorie drink has been shown to help people who are already thin increase their energy expenditure according to a study published Monday in the journal of Obesity, USA Today reported.

In the study funded by Nestle, Swiss researchers had 31 lean, young adults drink three cans of Enviga for three days.

On the third day, participants burned on average 106 extra calories or the equivalent of two regular Oreo cookies.

Last week the non-profit Center for Science in the Public Interest filed suit against the manufacturers, accusing them of fraudulent marketing and labeling.

The director of nutrition and health policy for Coca-Cola says Enviga is not being positioned as a weight-loss product.

Copyright 2007 by United Press International

Related Stories

Recommended for you

Best of Last Year—The top Medical Xpress articles of 2017

December 20, 2017
It was a good year for medical research as a team at the German center for Neurodegenerative Diseases, Magdeburg, found that dancing can reverse the signs of aging in the brain. Any exercise helps, the team found, but dancing ...

Pickled in 'cognac', Chopin's heart gives up its secrets

November 26, 2017
The heart of Frederic Chopin, among the world's most cherished musical virtuosos, may finally have given up the cause of his untimely death.

Sugar industry withheld evidence of sucrose's health effects nearly 50 years ago

November 21, 2017
A U.S. sugar industry trade group appears to have pulled the plug on a study that was producing animal evidence linking sucrose to disease nearly 50 years ago, researchers argue in a paper publishing on November 21 in the ...

Female researchers pay more attention to sex and gender in medicine

November 7, 2017
When women participate in a medical research paper, that research is more likely to take into account the differences between the way men and women react to diseases and treatments, according to a new study by Stanford researchers.

Drug therapy from lethal bacteria could reduce kidney transplant rejection

August 3, 2017
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.

Exploring the potential of human echolocation

June 25, 2017
People who are visually impaired will often use a cane to feel out their surroundings. With training and practice, people can learn to use the pitch, loudness and timbre of echoes from the cane or other sounds to navigate ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.